Imvaria
The AI engine Fit Assessment
BetaIMVARIA leverages machine learning to enhance patient outcomes through novel pattern discovery and the expansion of therapeutics, focusing on digital biomarker identification.
Blurb
IMVARIA brings artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases.
HQ Location
United States
Founded
2019
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Seed, April 30, 2020
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Biomarker Identification
Developer of a digital biomarker designed to enhance patient outcomes. The company's digital biomarkers use modern computer science techniques for solving complex and serious clinical problems and provide non-invasive diagnostic and therapeutic patient stratification via data science and machine learning decision-making, enabling clinicians to make the best decisions.